• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Miromatrix Medical Inc.

Baxter, Miromatrix partner on liver failure research

February 1, 2023 By Sean Whooley

Baxter (NYSE:BAX) and Miromatrix Medical (Nasdaq:MIRO) today announced a collaborative research agreement on acute liver failure (ALF) treatments. As part of the collaboration, Eden Prairie, Minnesota-based Miromatrix created a new liver therapy. The therapy, called MiroLiverELAP, combines a Miromatrix single-use bioengineered liver with Baxter’s PrisMax system. Miromatrix designed the MiroLiverELAP to provide external support to […]

Filed Under: Business/Financial News, Clinical Trials, Dialysis, Featured, News Well, Research & Development, Transplants Tagged With: Baxter, Miromatrix Medical Inc.

MiroMatrix raises $23m for decellularizing tech

August 31, 2015 By Fink Densford

Decellularization technology developer MiroMatrix Medical raised $23 million in a new round of equity financing, according to an SEC filing posted last week. MiroMatrix develops and utilizes a proprietary technology to remove cells, or decellularize, organs and tissue. Currently, MiroMatrix has 510(k) clearance for its MiroMesh biological mesh used during hernia repair procedures and as a […]

Filed Under: Business/Financial News, Regenerative Medicine Tagged With: Miromatrix Medical Inc.

Is Boston Scientific in line for a private equity takeover? | Wall Street Beat

February 24, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Billionaire hedge fund manager David Tepper, of Appaloosa Management, bought 7.8 million shares of Boston Scientific stock during the 4th quarter, according to regulatory filings, for a stake with a market value of $41.6 million as of Dec. 31.

Filed Under: Funding Roundup, Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: 3m, Aloka Co., Baxter, Boston Scientific, Burrill & Co., Cerner Corp., Conceptus Inc., Deals Roundup, Dexcom, integer, Integra LifeSciences, Lantheus Medical Imaging, McKesson Corp., MGT Capital, Miromatrix Medical Inc., Orchid Orthopedic, Revolutions Medical Corp., Sandvik, SpectraScience Inc., Teleflex, titanmedical, wrightmedical

Voice-command health IT firm launches with $650,000 | Funding roundup

May 8, 2011 By MedCity News Leave a Comment

Funding

A group of Cincinnati gastroenterologists have been joined by several business and technology partners to launch a health IT company that develops intraoperative voice-command software to document surgical procedures.

The company, eMerge Health Solutions, received $650,000 in investment commitments, including $250,000 from state-supported venture development group CincyTech.

Filed Under: News Well Tagged With: Awarepoint Corp., Cardiac Network Inc., Dexcom, eMerge Health Solutions, InspireMD, Miromatrix Medical Inc., Venture Capital/Private Equity

UMinn spinoff kicks founder off board | Personnel moves

April 12, 2011 By MassDevice staff Leave a Comment

MassDevice.com Personnel Moves

Founders of companies often clash with CEOs hired to operate the business. But at Miromatrix Medical Inc., a regenerative medicine firm spun out of the University of Minnesota, it happened just over a year after the company began operations.

The company was spun out of UMinn in December 2009 and formally set up in February 2010 when the university signed an exclusive licensing agreement allowing the research of Doris Taylor to be commercialized.

Filed Under: News Well Tagged With: Cleveland Clinic, Mascoma Corp., MiMedx Group Inc., Miromatrix Medical Inc., Personnel Moves, Revolutions Medical Corp.

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy